Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca

Show simple item record

dc.contributor.author Cisneros-Barroso, E.
dc.contributor.author Gorram, F.
dc.contributor.author Ribot-Sansó, M.A.
dc.contributor.author Alarcon, F.
dc.contributor.author Nuel, G.
dc.contributor.author González-Moreno, J.
dc.contributor.author Rodríguez, A.
dc.contributor.author Hernandez-Rodriguez, J.
dc.contributor.author Amengual-Cladera, E.
dc.contributor.author Martínez-López, I.
dc.contributor.author Ripoll-Vera, T.
dc.contributor.author Losada-López, I.
dc.contributor.author Heine-Suñer, D.
dc.contributor.author Plante-Bordeneuve, V.
dc.date.accessioned 2024-02-06T09:10:40Z
dc.date.available 2024-02-06T09:10:40Z
dc.identifier.uri http://hdl.handle.net/11201/164543
dc.description.abstract Background Variant transthyretin amyloidosis (A-ATTRv) is an autosomal dominant disease caused by a range of TTR gene variants which entail great phenotypical heterogeneity and penetrance. In Majorca, the A-ATTRv caused by the V30M gene variant (A-ATTRV30M) is the most common. Since asymptomatic carriers are at risk of developing the disease, estimating age of onset is vital for proper management and follow-up. Thus, the aim of this study was to estimate age-related penetrance in ATTRV30M variant carriers from Majorca. Methods The disease risk among carriers from ATTRV30M families from Majorca was estimated by Non-parametric survival estimation. Factors potentially involved in the disease expression, namely gender and parent of origin were also analysed. Results A total of 48 heterozygous ATTRV30M families (147 afected patients and 123 were asymptomatic carriers) were included in the analysis. Penetrance progressively increased from 6% at 30 years to 75% at 90 years of age. In contrast to other European populations, we observe a similar risk for both males and females, and no diference of risk according to the parent of origin. Conclusions In this frst study assessing the age-related penetrance of ATTRV30M variant in Majorcan families, no efect of gender or parent of origin was observed. These fndings will be helpful for improving management and follow-up of TTR variant carrier individuals.
dc.format application/pdf
dc.relation.isformatof
dc.relation.ispartof Orphanet Journal Of Rare Diseases, 2023
dc.rights , 2023
dc.subject.classification 57 - Biologia
dc.subject.classification Ciències de la salut
dc.subject.classification 61 - Medicina
dc.subject.other 57 - Biological sciences in general
dc.subject.other Medical sciences
dc.subject.other 61 - Medical sciences
dc.title Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca
dc.type info:eu-repo/semantics/article
dc.date.updated 2024-02-06T09:10:41Z
dc.rights.accessRights info:eu-repo/semantics/openAccess


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Repository


Advanced Search

Browse

My Account

Statistics